{"id":915737,"date":"2025-12-03T11:24:52","date_gmt":"2025-12-03T16:24:52","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/cardio-diagnostics-receives-final-gapfill-payment-rates-for-ai-driven-cardiovascular-tests-from-the-centers-for-medicare-and-medicaid-services-cms\/"},"modified":"2025-12-03T11:24:52","modified_gmt":"2025-12-03T16:24:52","slug":"cardio-diagnostics-receives-final-gapfill-payment-rates-for-ai-driven-cardiovascular-tests-from-the-centers-for-medicare-and-medicaid-services-cms","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cardio-diagnostics-receives-final-gapfill-payment-rates-for-ai-driven-cardiovascular-tests-from-the-centers-for-medicare-and-medicaid-services-cms\/","title":{"rendered":"Cardio Diagnostics Receives Final Gapfill Payment Rates for AI-Driven Cardiovascular Tests from the Centers for Medicare and Medicaid Services (CMS)"},"content":{"rendered":"<p>        <!--body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p><b>Cardio Diagnostics Receives Final Gapfill Payment Rates for AI-Driven Cardiovascular Tests from the Centers for Medicare and Medicaid Services (CMS)<\/b><\/p>\n<p><i>The final gapfill payment rate for both the Epi+Gen CHD\u2122 and PrecisionCHD\u2122 tests is higher at $854 compared to the preliminary gapfill payment rates of $350 for Epi+Gen CHD\u2122 and $684.76 for PrecisionCHD\u2122.<\/i><\/p>\n<p>CHICAGO&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.cdio.ai%2F&amp;esheet=54367747&amp;newsitemid=20251203479342&amp;lan=en-US&amp;anchor=Cardio+Diagnostics+Holdings%2C+Inc.&amp;index=1&amp;md5=d845e01bfbbb86473997b52956558705\">Cardio Diagnostics Holdings, Inc.<\/a> (Nasdaq: CDIO), an AI-powered precision cardiovascular medicine company, today announced that the Centers for Medicare and Medicaid Services (CMS) has issued a final gapfill payment rate of $854 for both the Epi+Gen CHD\u2122 and PrecisionCHD\u2122 tests. This finalized rate represents an increase from the preliminary gapfill payment rates of $350 for Epi+Gen CHD\u2122 and $684.76 for PrecisionCHD\u2122. Obtaining the final rate represents a positive development and will be effective for claims with dates of service on or after January 1, 2026.\n<\/p>\n<p>\n\u201cWe are pleased with the final payment rate,\u201d said Meesha Dogan, PhD., CEO and Co-Founder of Cardio Diagnostics. \u201cObtaining the final rate is a significant step in our efforts to expand access to our advanced cardiovascular tests for Medicare beneficiaries.\u201d\n<\/p>\n<p>\nCardiovascular disease remains the leading cause of death in the United States, particularly among Americans aged 65 and older. In 2022 alone, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.cdc.gov%2Fheart-disease%2Fdata-research%2Ffacts-stats%2Findex.html&amp;esheet=54367747&amp;newsitemid=20251203479342&amp;lan=en-US&amp;anchor=over+700%2C000+Americans+died+from+heart+disease&amp;index=2&amp;md5=0c632b4263fca5b3cb603977b304cee1\">over 700,000 Americans died from heart disease<\/a>, with coronary heart disease (CHD) accounting for more than 370,000 deaths.\n<\/p>\n<p>\nPrecisionCHD\u2122 is a groundbreaking AI-powered test designed to aid in the diagnosis of CHD by analyzing both genetic and epigenetic markers. Meanwhile, Epi+Gen CHD\u2122<b \/>provides insight into a patient\u2019s three-year risk for a CHD event, such as a heart attack. Both tests are performed from a simple blood draw, enabling scalable, accessible, and non-invasive cardiovascular assessment. Both tests received dedicated CPT Proprietary Laboratory Analysis (PLA) codes from the American Medical Association, 0439U for Epi+Gen CHD and 0440U for PrecisionCHD, that became effective on April 1, 2024.\n<\/p>\n<p>\nAbout Cardio Diagnostics\n<\/p>\n<p>\nCardio Diagnostics is an artificial intelligence-powered precision cardiovascular medicine company that makes cardiovascular disease prevention, detection, and management more accessible, personalized, and precise. The Company was formed to further develop and commercialize clinical tests by leveraging a proprietary Artificial Intelligence (AI)-driven Integrated Genetic-Epigenetic Engine (\u201cCore Technology\u201d) for cardiovascular disease to become one of the leading medical technology companies for improving prevention, detection, and treatment of cardiovascular disease. For more information, please visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fcdio.ai%2F&amp;esheet=54367747&amp;newsitemid=20251203479342&amp;lan=en-US&amp;anchor=https%3A%2F%2Fcdio.ai%2F&amp;index=3&amp;md5=4b7621ecdfe17bd74b82dc2959077a63\">https:\/\/cdio.ai\/<\/a>.\n<\/p>\n<p>\nForward-Looking Statements\n<\/p>\n<p>\nCertain statements and information included in this press release constitute \u201cforward-looking statements\u201d within the meaning of the Private Securities Litigation Act of 1995. When used in this press release, the words or phrases \u201cwill\u201d, \u201cwill likely result,\u201d \u201cexpected to,\u201d \u201cwill continue,\u201d \u201canticipated,\u201d \u201cestimate,\u201d \u201cprojected,\u201d \u201cintend,\u201d \u201cgoal,\u201d or similar expressions are intended to identify \u201cforward-looking statements\u201d within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks, known and unknown, and uncertainties, many of which are beyond the control of the Company. Such uncertainties and risks include but are not limited to, our ability to successfully execute our growth strategy, changes in laws or regulations, economic conditions, and dependence on results as discussed in the Annual Report on Form 10-K for the period ended December 31, 2024, under the heading \u201cRisk Factors\u201d in Part I, Item IA thereof, and other documents filed from time to time with the Securities and Exchange Commission. Such factors could materially adversely affect the Company\u2019s financial performance and could cause the Company\u2019s actual results for future periods to differ materially from any opinions or statements expressed within this press release.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20251203479342r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20251203479342\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20251203479342\/en\/<\/a><\/span><\/p>\n<p><b>Investors<br \/>\n<\/b><br \/>Investor Relations<br \/>\n<br \/>855-226-9991<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:investors@cdio.ai\">investors@cdio.ai<\/a><\/p>\n<p><b>Media &amp; Public Relations<br \/>\n<\/b><br \/>Public Relations<br \/>\n<br \/>855-226-9991<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:pr@cdio.ai\">pr@cdio.ai<\/a><\/p>\n<p><b>KEYWORDS:<\/b> Illinois United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Technology Health Technology Software Other Health Biotechnology General Health Pharmaceutical Health Data Management Artificial Intelligence<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20251203479342\/en\/2659437\/3\/CARDIO_LOGO.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Cardio Diagnostics Receives Final Gapfill Payment Rates for AI-Driven Cardiovascular Tests from the Centers for Medicare and Medicaid Services (CMS) The final gapfill payment rate for both the Epi+Gen CHD\u2122 and PrecisionCHD\u2122 tests is higher at $854 compared to the preliminary gapfill payment rates of $350 for Epi+Gen CHD\u2122 and $684.76 for PrecisionCHD\u2122. CHICAGO&#8211;(BUSINESS WIRE)&#8211;Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), an AI-powered precision cardiovascular medicine company, today announced that the Centers for Medicare and Medicaid Services (CMS) has issued a final gapfill payment rate of $854 for both the Epi+Gen CHD\u2122 and PrecisionCHD\u2122 tests. This finalized rate represents an increase from the preliminary gapfill payment rates of $350 for Epi+Gen CHD\u2122 and $684.76 for PrecisionCHD\u2122. Obtaining the final rate represents &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cardio-diagnostics-receives-final-gapfill-payment-rates-for-ai-driven-cardiovascular-tests-from-the-centers-for-medicare-and-medicaid-services-cms\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Cardio Diagnostics Receives Final Gapfill Payment Rates for AI-Driven Cardiovascular Tests from the Centers for Medicare and Medicaid Services (CMS)&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-915737","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cardio Diagnostics Receives Final Gapfill Payment Rates for AI-Driven Cardiovascular Tests from the Centers for Medicare and Medicaid Services (CMS) - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cardio-diagnostics-receives-final-gapfill-payment-rates-for-ai-driven-cardiovascular-tests-from-the-centers-for-medicare-and-medicaid-services-cms\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cardio Diagnostics Receives Final Gapfill Payment Rates for AI-Driven Cardiovascular Tests from the Centers for Medicare and Medicaid Services (CMS) - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Cardio Diagnostics Receives Final Gapfill Payment Rates for AI-Driven Cardiovascular Tests from the Centers for Medicare and Medicaid Services (CMS) The final gapfill payment rate for both the Epi+Gen CHD\u2122 and PrecisionCHD\u2122 tests is higher at $854 compared to the preliminary gapfill payment rates of $350 for Epi+Gen CHD\u2122 and $684.76 for PrecisionCHD\u2122. CHICAGO&#8211;(BUSINESS WIRE)&#8211;Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), an AI-powered precision cardiovascular medicine company, today announced that the Centers for Medicare and Medicaid Services (CMS) has issued a final gapfill payment rate of $854 for both the Epi+Gen CHD\u2122 and PrecisionCHD\u2122 tests. This finalized rate represents an increase from the preliminary gapfill payment rates of $350 for Epi+Gen CHD\u2122 and $684.76 for PrecisionCHD\u2122. Obtaining the final rate represents &hellip; Continue reading &quot;Cardio Diagnostics Receives Final Gapfill Payment Rates for AI-Driven Cardiovascular Tests from the Centers for Medicare and Medicaid Services (CMS)&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cardio-diagnostics-receives-final-gapfill-payment-rates-for-ai-driven-cardiovascular-tests-from-the-centers-for-medicare-and-medicaid-services-cms\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-03T16:24:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20251203479342r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cardio-diagnostics-receives-final-gapfill-payment-rates-for-ai-driven-cardiovascular-tests-from-the-centers-for-medicare-and-medicaid-services-cms\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cardio-diagnostics-receives-final-gapfill-payment-rates-for-ai-driven-cardiovascular-tests-from-the-centers-for-medicare-and-medicaid-services-cms\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Cardio Diagnostics Receives Final Gapfill Payment Rates for AI-Driven Cardiovascular Tests from the Centers for Medicare and Medicaid Services (CMS)\",\"datePublished\":\"2025-12-03T16:24:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cardio-diagnostics-receives-final-gapfill-payment-rates-for-ai-driven-cardiovascular-tests-from-the-centers-for-medicare-and-medicaid-services-cms\\\/\"},\"wordCount\":648,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cardio-diagnostics-receives-final-gapfill-payment-rates-for-ai-driven-cardiovascular-tests-from-the-centers-for-medicare-and-medicaid-services-cms\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20251203479342r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cardio-diagnostics-receives-final-gapfill-payment-rates-for-ai-driven-cardiovascular-tests-from-the-centers-for-medicare-and-medicaid-services-cms\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cardio-diagnostics-receives-final-gapfill-payment-rates-for-ai-driven-cardiovascular-tests-from-the-centers-for-medicare-and-medicaid-services-cms\\\/\",\"name\":\"Cardio Diagnostics Receives Final Gapfill Payment Rates for AI-Driven Cardiovascular Tests from the Centers for Medicare and Medicaid Services (CMS) - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cardio-diagnostics-receives-final-gapfill-payment-rates-for-ai-driven-cardiovascular-tests-from-the-centers-for-medicare-and-medicaid-services-cms\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cardio-diagnostics-receives-final-gapfill-payment-rates-for-ai-driven-cardiovascular-tests-from-the-centers-for-medicare-and-medicaid-services-cms\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20251203479342r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2025-12-03T16:24:52+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cardio-diagnostics-receives-final-gapfill-payment-rates-for-ai-driven-cardiovascular-tests-from-the-centers-for-medicare-and-medicaid-services-cms\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cardio-diagnostics-receives-final-gapfill-payment-rates-for-ai-driven-cardiovascular-tests-from-the-centers-for-medicare-and-medicaid-services-cms\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cardio-diagnostics-receives-final-gapfill-payment-rates-for-ai-driven-cardiovascular-tests-from-the-centers-for-medicare-and-medicaid-services-cms\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20251203479342r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20251203479342r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cardio-diagnostics-receives-final-gapfill-payment-rates-for-ai-driven-cardiovascular-tests-from-the-centers-for-medicare-and-medicaid-services-cms\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cardio Diagnostics Receives Final Gapfill Payment Rates for AI-Driven Cardiovascular Tests from the Centers for Medicare and Medicaid Services (CMS)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cardio Diagnostics Receives Final Gapfill Payment Rates for AI-Driven Cardiovascular Tests from the Centers for Medicare and Medicaid Services (CMS) - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cardio-diagnostics-receives-final-gapfill-payment-rates-for-ai-driven-cardiovascular-tests-from-the-centers-for-medicare-and-medicaid-services-cms\/","og_locale":"en_US","og_type":"article","og_title":"Cardio Diagnostics Receives Final Gapfill Payment Rates for AI-Driven Cardiovascular Tests from the Centers for Medicare and Medicaid Services (CMS) - Market Newsdesk","og_description":"Cardio Diagnostics Receives Final Gapfill Payment Rates for AI-Driven Cardiovascular Tests from the Centers for Medicare and Medicaid Services (CMS) The final gapfill payment rate for both the Epi+Gen CHD\u2122 and PrecisionCHD\u2122 tests is higher at $854 compared to the preliminary gapfill payment rates of $350 for Epi+Gen CHD\u2122 and $684.76 for PrecisionCHD\u2122. CHICAGO&#8211;(BUSINESS WIRE)&#8211;Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), an AI-powered precision cardiovascular medicine company, today announced that the Centers for Medicare and Medicaid Services (CMS) has issued a final gapfill payment rate of $854 for both the Epi+Gen CHD\u2122 and PrecisionCHD\u2122 tests. This finalized rate represents an increase from the preliminary gapfill payment rates of $350 for Epi+Gen CHD\u2122 and $684.76 for PrecisionCHD\u2122. Obtaining the final rate represents &hellip; Continue reading \"Cardio Diagnostics Receives Final Gapfill Payment Rates for AI-Driven Cardiovascular Tests from the Centers for Medicare and Medicaid Services (CMS)\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cardio-diagnostics-receives-final-gapfill-payment-rates-for-ai-driven-cardiovascular-tests-from-the-centers-for-medicare-and-medicaid-services-cms\/","og_site_name":"Market Newsdesk","article_published_time":"2025-12-03T16:24:52+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20251203479342r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cardio-diagnostics-receives-final-gapfill-payment-rates-for-ai-driven-cardiovascular-tests-from-the-centers-for-medicare-and-medicaid-services-cms\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cardio-diagnostics-receives-final-gapfill-payment-rates-for-ai-driven-cardiovascular-tests-from-the-centers-for-medicare-and-medicaid-services-cms\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Cardio Diagnostics Receives Final Gapfill Payment Rates for AI-Driven Cardiovascular Tests from the Centers for Medicare and Medicaid Services (CMS)","datePublished":"2025-12-03T16:24:52+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cardio-diagnostics-receives-final-gapfill-payment-rates-for-ai-driven-cardiovascular-tests-from-the-centers-for-medicare-and-medicaid-services-cms\/"},"wordCount":648,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cardio-diagnostics-receives-final-gapfill-payment-rates-for-ai-driven-cardiovascular-tests-from-the-centers-for-medicare-and-medicaid-services-cms\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20251203479342r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cardio-diagnostics-receives-final-gapfill-payment-rates-for-ai-driven-cardiovascular-tests-from-the-centers-for-medicare-and-medicaid-services-cms\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cardio-diagnostics-receives-final-gapfill-payment-rates-for-ai-driven-cardiovascular-tests-from-the-centers-for-medicare-and-medicaid-services-cms\/","name":"Cardio Diagnostics Receives Final Gapfill Payment Rates for AI-Driven Cardiovascular Tests from the Centers for Medicare and Medicaid Services (CMS) - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cardio-diagnostics-receives-final-gapfill-payment-rates-for-ai-driven-cardiovascular-tests-from-the-centers-for-medicare-and-medicaid-services-cms\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cardio-diagnostics-receives-final-gapfill-payment-rates-for-ai-driven-cardiovascular-tests-from-the-centers-for-medicare-and-medicaid-services-cms\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20251203479342r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2025-12-03T16:24:52+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cardio-diagnostics-receives-final-gapfill-payment-rates-for-ai-driven-cardiovascular-tests-from-the-centers-for-medicare-and-medicaid-services-cms\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cardio-diagnostics-receives-final-gapfill-payment-rates-for-ai-driven-cardiovascular-tests-from-the-centers-for-medicare-and-medicaid-services-cms\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cardio-diagnostics-receives-final-gapfill-payment-rates-for-ai-driven-cardiovascular-tests-from-the-centers-for-medicare-and-medicaid-services-cms\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20251203479342r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20251203479342r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cardio-diagnostics-receives-final-gapfill-payment-rates-for-ai-driven-cardiovascular-tests-from-the-centers-for-medicare-and-medicaid-services-cms\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Cardio Diagnostics Receives Final Gapfill Payment Rates for AI-Driven Cardiovascular Tests from the Centers for Medicare and Medicaid Services (CMS)"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/915737","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=915737"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/915737\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=915737"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=915737"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=915737"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}